Overview
Status
Active
Registry date
2016-09-16
Share capital
10 000,00 PLN
Registered address
ul. Knyszyńska 16A/2, 80-180 Gdańsk, Poland
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 68 days late).
- 202516/04/2026
- 202426/05/2025
- 202310/06/2024
- 202215/07/2023
- 202121/09/2022
- 202023/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 27.89MedianUSD 164.14kAverageUSD 2.27m
Net profit
This companyUSD -98.97kMedianUSD 1.03kAverageUSD 108.21k
Operating costs
This companyUSD 1.77kMedianUSD 187.05kAverageUSD 2.07m
Assets
This companyUSD 2.07kMedianUSD 115.76kAverageUSD 1.52m
Industry
Authorized Representatives
Zbigniew Nowak – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Zbigniew Nowakage 70 | 99 | $2,674.23 | 99% |
Others | 1 | $27.01 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2016-10-25 to 2026-01-29.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 25, 2024 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-10-13 | Business resumed | |
| 2024-03-22 | Name change (Pharmafoods → Pharmafoods Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2024-03-01 | Liquidation opened | |
| 2023-10-12 | Business suspended | |
| 2023-10-11 | Business resumed |
FAQ
The main business activity of Pharmafoods focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on September 16, 2016.
The headquarters is located at: ul. Knyszyńska 16A, 80-180 Gdańsk.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $28.
No, the company recorded a net loss of $98,970 in 2025. For comparison, in 2024 the loss was $4,461, representing a multi-fold increase in the loss compared to 2024.
The largest operating cost category falls under external services. This category amounted to $1,747 in 2025, representing 99% of all operating expenses.
Last updated: 2026-04-19